Artificial Intelligence

Artificial intelligence (AI) is becoming a crucial component of healthcare to help augment physicians and make them more efficient. In medical imaging, it is helping radiologists more efficiently manage PACS worklists, enable structured reporting, auto detect injuries and diseases, and to pull in relevant prior exams and patient data. In cardiology, AI is helping automate tasks and measurements on imaging and in reporting systems, guides novice echo users to improve imaging and accuracy, and can risk stratify patients. AI includes deep learning algorithms, machine learning, computer-aided detection (CAD) systems, and convolutional neural networks.

FDA clears new AI model for detecting signs of cardiac amyloidosis
This is the second FDA clearance in two weeks for Massachusetts-based Anumana. The company's AI models are built to evaluate ECG results for signs of various cardiovascular conditions.
FDA denies petition to exempt certain radiology AI devices from premarket review
In October, Harrison.ai submitted a citizen petition seeking greater flexibility in the 520(k) clearance process for certain computer-aided detection devices.
Medicare navigation company raises $100M to improve its AI, launch new financial products
Chapter, a technology company based in New York City, said it tripled its revenue last year by filling a market niche designing technology for seniors—specifically, those who have questions about the Medicare program.
Dying former US senator: ‘Will AI bring heaven or hell? Yes.’
Ben Sasse is showing the effects of the terminal pancreatic cancer he was diagnosed with late last year. Yet he’s still in good spirits and his mental energy remains high.
Imaging AI targeting Parkinson's earns FDA's De Novo classification
The diffusion MRI software helps differentiate between Parkinson’s disease, atypical parkinsonism, multiple system atrophy Parkinsonian variant and progressive supranuclear palsy.

artificial intelligence AI heart cardiology

FDA clears new AI model for detecting signs of cardiac amyloidosis

This is the second FDA clearance in two weeks for Massachusetts-based Anumana. The company's AI models are built to evaluate ECG results for signs of various cardiovascular conditions.

FDA denies petition to exempt certain radiology AI devices from premarket review

In October, Harrison.ai submitted a citizen petition seeking greater flexibility in the 520(k) clearance process for certain computer-aided detection devices.

Medicare navigation company raises $100M to improve its AI, launch new financial products

Chapter, a technology company based in New York City, said it tripled its revenue last year by filling a market niche designing technology for seniors—specifically, those who have questions about the Medicare program.

Dying former US senator: ‘Will AI bring heaven or hell? Yes.’

Ben Sasse is showing the effects of the terminal pancreatic cancer he was diagnosed with late last year. Yet he’s still in good spirits and his mental energy remains high.

Imaging AI targeting Parkinson's earns FDA's De Novo classification

The diffusion MRI software helps differentiate between Parkinson’s disease, atypical parkinsonism, multiple system atrophy Parkinsonian variant and progressive supranuclear palsy.

AI artificial intelligence stethoscope doctor

AI is everywhere ... except in radiology job postings, new data reveal

Talk of artificial intelligence in radiology is commonplace these days, but a new report suggests that employers are remaining mum on the topic when it comes to job descriptions.

Patients feeling less sure about medical AI these days

Consumer affinity for AI in healthcare has plummeted over the past two years, a new survey report shows.

Cybersecurity experts believe AI is changing their work at a ‘fundamental’ level

Is the edge with the cybercriminals looking for weak points in firewalls? Or the security professionals trying to stop the bad guys from finding any?